Skip to content

Press

Portfolio-Media Coverage
Nido Biosciences raises $109m in funding for neurological diseases treatments
May 16, 2023 May 16, 2023 PharmaFile
Portfolio-Media Coverage
Nido Bio – 5AM Ventures leads $109 million bet on precision drug start-up
May 16, 2023 May 16, 2023 PharmaLetter
Portfolio-Press Releases
Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases
May 15, 2023 May 15, 2023
Portfolio-Media Coverage
New Eli Lilly-backed neurological disease biotech Nido unveils with $109M
May 15, 2023 May 15, 2023 Fierce Biotech
Portfolio-Media Coverage
Lilly-Backed Nido Biosciences Launches with $109M to Target Neurological Diseases
May 15, 2023 May 15, 2023 Biospace
Portfolio-Media Coverage
Startup Nido Bio Reveals $109M (so far) for Precision Approach to Neuro Disorder
May 15, 2023 May 15, 2023 MedCity News
Portfolio-Media Coverage
Nido Bio launches to develop small-molecule drugs for neurological diseases
May 15, 2023 May 15, 2023 Firstword Pharma
Portfolio-Media Coverage
Nido Biosciences Secures $109 Million to Advance Precision Medicines for Neurological Diseases
May 15, 2023 May 15, 2023 Silicon Valley Journals
Portfolio-Media Coverage
Nido Biosciences raises $109M to drug novel targets in neurological disease
May 15, 2023 May 15, 2023 Bioworld
Portfolio-Media Coverage
Nido Bio – Five years after founding, neuroscience startup emerges with $109M
May 15, 2023 May 15, 2023 BizJournals